Neurology Drugs Market Size, Share & Industry Analysis, By Indication (Alzheimer's Disease, Multiple Sclerosis, Epilepsy, Parkinson's Disease, and Others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Antiepileptic Drugs, Immunomodulatory Drugs, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI113562

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Neurological Disorders, By Key Countries/Regions
2. Regolatory Framework, By Key Countries/Regions
3. Reimbursement Scenario, By Key Countries/Regions
4. New Product Launches & Approvals, By Key Players
5. Key Industry Developments (Merger, Acquisition, Collaboration, etc.)
Global Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe

Asia Pacific Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Eisai Co., Ltd.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  2. Strategies
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  3. Biogen Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  4. Bayer AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  5. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  6. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  7. Novartis AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  8. Merck KGaA
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  9. Sanofi
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  10. AbbVie Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Neurological Disorders, By Key Countries/Regions
2. Regolatory Framework, By Key Countries/Regions
3. Reimbursement Scenario, By Key Countries/Regions
4. New Product Launches & Approvals, By Key Players
5. Key Industry Developments (Merger, Acquisition, Collaboration, etc.)
Global Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe

Asia Pacific Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Neurology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Indication
  1. Alzheimer's Disease
  2. Moltiple Sclerosis
  3. Epilepsy
  4. Parkinson's Disease
  5. Others
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Cholinesterase Inhibitors
  2. NMDA Receptor Antagonist
  3. Antiepileptic Drugs
  4. Immunomodolatory Drugs
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Eisai Co., Ltd.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  2. Strategies
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  3. Biogen Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  4. Bayer AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  5. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  6. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  7. Novartis AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  8. Merck KGaA
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  9. Sanofi
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.
  10. AbbVie Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, etc.

Read Less

List of Figures

Figure 1: Global Neurology Drugs Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Neurology Drugs Market Value Share (%), By Indication, 2024 & 2032

Figure 3: Global Neurology Drugs Market Value Share (%), By Drug Class, 2024 & 2032

Figure 4: Global Neurology Drugs Market Value Share (%), By Route of Administration, 2024 & 2032

Figure 5: Global Neurology Drugs Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 6: Global Neurology Drugs Market Value (USD billion), by Region, 2024 & 2032

Figure 7: North America Neurology Drugs Market Value (USD billion), By Indication, 2024 & 2032

Figure 8: North America Neurology Drugs Market Value Share (%), By Indication, 2024

Figure 9: North America Neurology Drugs Market Value (USD billion), By Drug Class, 2024 & 2032

Figure 10: North America Neurology Drugs Market Value Share (%), By Drug Class, 2024

Figure 11: North America Neurology Drugs Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 12: North America Neurology Drugs Market Value Share (%), By Route of Administration, 2024

Figure 13: North America Neurology Drugs Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 14: North America Neurology Drugs Market Value Share (%), By Distribution Channel, 2024

Figure 15: North America Neurology Drugs Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America Neurology Drugs Market Value Share (%), By Country, 2024

Figure 17: Europe Neurology Drugs Market Value (USD billion), By Indication, 2024 & 2032

Figure 18: Europe Neurology Drugs Market Value Share (%), By Indication, 2024

Figure 19: Europe Neurology Drugs Market Value (USD billion), By Drug Class, 2024 & 2032

Figure 20: Europe Neurology Drugs Market Value Share (%), By Drug Class, 2024

Figure 21: Europe Neurology Drugs Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 22: Europe Neurology Drugs Market Value Share (%), By Route of Administration, 2024

Figure 23: Europe Neurology Drugs Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 24: Europe Neurology Drugs Market Value Share (%), By Distribution Channel, 2024

Figure 25: Europe Neurology Drugs Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 26: Europe Neurology Drugs Market Value Share (%), By Country/Sub-Region, 2024

Figure 27: Asia Pacific Neurology Drugs Market Value (USD billion), By Indication, 2024 & 2032

Figure 28: Asia Pacific Neurology Drugs Market Value Share (%), By Indication, 2024

Figure 29: Asia Pacific Neurology Drugs Market Value (USD billion), By Drug Class, 2024 & 2032

Figure 30: Asia Pacific Neurology Drugs Market Value Share (%), By Drug Class, 2024

Figure 31: Asia Pacific Neurology Drugs Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 32: Asia Pacific Neurology Drugs Market Value Share (%), By Route of Administration, 2024

Figure 33: Asia Pacific Neurology Drugs Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific Neurology Drugs Market Value Share (%), By Distribution Channel, 2024

Figure 35: Asia Pacific Neurology Drugs Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 36: Asia Pacific Neurology Drugs Market Value Share (%), By Country/Sub-Region, 2024

Figure 37: Latin America Neurology Drugs Market Value (USD billion), By Indication, 2024 & 2032

Figure 38: Latin America Neurology Drugs Market Value Share (%), By Indication, 2024

Figure 39: Latin America Neurology Drugs Market Value (USD billion), By Drug Class, 2024 & 2032

Figure 40: Latin America Neurology Drugs Market Value Share (%), By Drug Class, 2024

Figure 41: Latin America Neurology Drugs Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 42: Latin America Neurology Drugs Market Value Share (%), By Route of Administration, 2024

Figure 43: Latin America Neurology Drugs Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 44: Latin America Neurology Drugs Market Value Share (%), By Distribution Channel, 2024

Figure 45: Latin America Neurology Drugs Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 46: Latin America Neurology Drugs Market Value Share (%), By Country/Sub-Region, 2024

Figure 47: Middle East & Africa Neurology Drugs Market Value (USD billion), By Indication, 2024 & 2032

Figure 48: Middle East & Africa Neurology Drugs Market Value Share (%), By Indication, 2024

Figure 49: Middle East & Africa Neurology Drugs Market Value (USD billion), By Drug Class, 2024 & 2032

Figure 50: Middle East & Africa Neurology Drugs Market Value Share (%), By Drug Class, 2024

Figure 51: Middle East & Africa Neurology Drugs Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 52: Middle East & Africa Neurology Drugs Market Value Share (%), By Route of Administration, 2024

Figure 53: Middle East & Africa Neurology Drugs Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa Neurology Drugs Market Value Share (%), By Distribution Channel, 2024

Figure 55: Middle East & Africa Neurology Drugs Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 56: Middle East & Africa Neurology Drugs Market Value Share (%), By Country/Sub-Region, 2024

Figure 57: Global Neurology Drugs Market Share (%), By Company, 2024

List of Tables

Table 1: Global Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 2: Global Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 3: Global Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 4: Global Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 5: Global Neurology Drugs Market Revenue (USD billion) Forecast, by Region, 2019–2032

Table 6: North America Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 7: North America Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 8: North America Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 9: North America Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 10: North America Neurology Drugs Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 11: Europe Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 12: Europe Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 13: Europe Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 14: Europe Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 15: Europe Neurology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

Table 16: Asia Pacific Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 17: Asia Pacific Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 18: Asia Pacific Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 19: Asia Pacific Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 20: Asia Pacific Neurology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

Table 21: Latin America Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 22: Latin America Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 23: Latin America Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 24: Latin America Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 25: Latin America Neurology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

Table 26: Middle East & Africa Neurology Drugs Market Revenue (USD billion) Forecast, By Indication, 2019–2032

Table 27: Middle East & Africa Neurology Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2032

Table 28: Middle East & Africa Neurology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 29: Middle East & Africa Neurology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 30: Middle East & Africa Neurology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com